Illes Bernhard, Wuttke Stefan, Engelke Hanna
Department of Chemistry and Center for NanoScience (CeNS), LMU Munich, Butenandtstraße 11 (E), 81377 Munich, Germany.
School of Chemistry, Joseph Banks Laboratories, University of Lincoln, Lincoln LN67TS, UK.
Nanomaterials (Basel). 2017 Oct 26;7(11):351. doi: 10.3390/nano7110351.
One of the main problems for effective treatment of cancer is resistances, which often require combination therapy-for effective treatment. While there are already some potential drug carriers-e.g., liposomes, available for treatment-the effective loading and retention of the desired drug ratio can be challenging. To address this challenge, we propose a new type of drug carrier: liposome-coated metal-organic framework (MOF) nanoparticles. They combine the advantages of liposomes with an easy and efficient loading process. In this work, we present the successful synthesis of liposome-coated MOF nanoparticles via the fusion method. The resulting particles, once loaded, show no premature leakage and an efficient release. Their successful loading with both single and multiple drugs at the same time makes them an interesting candidate for use in combination therapy.
有效治疗癌症的主要问题之一是耐药性,这通常需要联合治疗才能有效治疗。虽然已经有一些潜在的药物载体,例如脂质体可用于治疗,但实现所需药物比例的有效负载和保留可能具有挑战性。为应对这一挑战,我们提出了一种新型药物载体:脂质体包覆的金属有机框架(MOF)纳米颗粒。它们结合了脂质体的优点以及简便高效的负载过程。在这项工作中,我们展示了通过融合方法成功合成脂质体包覆的MOF纳米颗粒。所得颗粒一旦负载药物,不会过早泄漏且能有效释放。它们能够同时成功负载单一药物和多种药物,使其成为联合治疗中一个有吸引力的候选者。